Zhang Lei,Davoren Jennifer Elizabeth,Dounay Amy Beth,Gray David Lawrence Firman,Henderson Jaclyn Louise,O’neil Steven Victor,Brodney Michael Aaron,Efremov Ivan Viktorovich,Green Michael Eric,Lee Chewa
申请号：
NZ71376214
公开号：
NZ713762A
申请日:
2014.06.13
申请国别(地区):
NZ
年份:
2018
代理人:
摘要：
The present invention provides, in part, compounds of Formula (I) and pharmaceutically acceptable salts thereof processes for the preparation of intermediates used in the preparation of and compositions containing such compounds or salts, and their uses for treating D1 -mediated (or D1 -associated) disorders including, e.g., schizophrenia (e.g., its cognitive and negative symptoms), cognitive impairment (e.g., cognitive impairment associated with schizophrenia, AD, PD, or pharmacotherapy therapy), age-related cognitive decline, dementia, and Parkinson’s disease.
